期刊文献+

FDG PET显像在判断鼻咽癌放疗后鼻咽病灶复发中的临床价值 被引量:1

Clinical value of FDG PET to detect recurrence of nasopharyngeal carcinoma after radiotherapy
下载PDF
导出
摘要 目的探讨脱氧葡萄糖正电子发射断层扫描(FDGPET)在鼻咽癌放射治疗后随诊中的临床价值以及与CT、MRI的互补作用。方法回顾性分析放射治疗后6~8个月、CT和MRI检查考虑鼻咽病灶复发的6例鼻咽癌患者,随后行FDG PET检查,并均作病理活检。结果6例CT和MRI提示肿瘤复发的鼻咽癌患者,PET显示其中2例有局灶性FDG代谢明显增高,经病理活检,证实仅2例FDG摄取浓聚的病变为肿瘤复发。结论与CT和MRI检查相比,FDG PET在鼻咽癌放射治疗后肿瘤复发的定性诊断上具有明显优势,若结合CT或MRI的影像结果分析,取得局部病变的结构与代谢改变复合信息,对后期局部复发病灶的精确适形放射治疗具有重要意义。 Objective To investigate the clinical value of FDG PET imaging in the follow-up of nasopharyngeal carcinoma after radiotherapy and complcmcntation with CT/MRI. Methods In our prognostic analysis, 6 patients with nasopharyngcal carcinoma were considered recurrence by CT and MRI during 6-8 months after radiotherapy. They also underwent FDG PET and biopsy. Results Two of six patients showed significantly increased FDG metabolism that diagnosed recurrence by CT and MRI scans. These were pathologically confirmed. Conclusion FDG PET imaging has an advantage in distinguishing the relapse in the follow-up of post-radiotherapy nasopharyngeal carcinoma patients. PET,CT and MRI is able to give a detail both in morphological and functional changes of disease. They are especially useful in the follow-up or the set-up treatment planning for recurrent nasopharyngeal carcinoma.
出处 《重庆医学》 CAS CSCD 2007年第20期2057-2058,共2页 Chongqing medicine
关键词 鼻咽恶性肿瘤 FDG PET 放射疗法 CT MRI nasopharyngeal tumor FDG PET radiotherapy CT MRI
  • 相关文献

参考文献12

  • 1梁利安,李少明,王萍实,罗耀武,唐安戊.PET脑显像及其他显像技术在放射性脑损伤诊断的对比性研究[J].现代临床医学生物工程学杂志,2002,8(2):113-115. 被引量:4
  • 2李立伟,金泉,刘京璇.正电子发射体层显像在肿瘤诊断中的初步应用——与CT、MRI和手术病理结果对照[J].中华放射学杂志,1999,33(4):242-245. 被引量:12
  • 3Ho CL. Clinical PET imaging-an Asian perspective [J]. Ann Acad Medingapore,2004,33(2):155. 被引量:1
  • 4Di Chiro,Oklfiekl A. Cerebral necrosis after radiotherapy and / or intraarterial chemotherapy for brain tumors:PET and neuropathologic studies[J]. AJR, 1988,150: 189. 被引量:1
  • 5Valk PE,Budingerte. PET of malignant cerebral tumors after interstitial brachytheraphy: Demonstration of metabolic activity and correction with clinical outcome [J]. J Neurosurg, 1988,69:830. 被引量:1
  • 6陈应瑞,辜梅新,李伟雄,潘燚.FDG PET判断鼻咽癌放疗后鼻咽病灶残留的临床价值[J].癌症,2002,21(6):651-653. 被引量:23
  • 7Kao CH,Changlai SP,Chieng PU,et al. Detection of recurrent or persistent nasopharyngeal carcinoma after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomo graphy[J]. J Clin Oncol,1998,16:3550. 被引量:1
  • 8Mitsuhashi N, Hayakawa K, Hasegawa M, et al. Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor[J]. Anti- cancer Res,1998,18:2827. 被引量:1
  • 9Kao CH,Tsai SC,Wang JJ,et al. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinoma after radiotherapy[J]. Cancer, 2001,92:434. 被引量:1
  • 10Chaiken L, Rege SD, Hoh CK, et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy[J]. Int J Radiat Oncol Biol Phys,1993,27:455. 被引量:1

二级参考文献13

  • 1张雪林,闫卫平,邹常敬,刘兴元,刘忠宇,卢晶.鼻咽癌放疗后放射性脑病的临床表现与MRI对照分析[J].中风与神经疾病杂志,1995,12(5):271-273. 被引量:5
  • 2颜海婴,王大有.鼻咽癌放疗后局部复发和纤维化的增强 CT 鉴别诊断价值[J].中华肿瘤杂志,1997,19(3):203-205. 被引量:23
  • 3Goerres GW, von Schulthess GK, Steinert HC, Why most PET of lung and head-and-neck cancer will be PET/CT [J]. J Nucl Med, 2004, 45(Suppll):66S-71S. 被引量:1
  • 4Pelosi E, Messa C, Sironi S, et al. Value of integrated PET/CT for lesion localisadon in cancer patients: a comparative study[J].Eur J Nud Med Mol Imaging, 2004, 31(7):932-939. 被引量:1
  • 5Schoder H, Larson SM, Yetmg HW, PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies[J]. J Nucl Med, 2004, 45 Suppll:72S-81S. 被引量:1
  • 6Wahl RL, Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT [J]. J Nucl Med, 2004, 45 Suppll:82S-95S. 被引量:1
  • 7Kluetz PG, Meltzer CC, Villemagne VL, et al. Combined PET/CT imaging in oncology impact on patient management [J], Clin Positron Imaging, 2000, 3(6): 223-230. 被引量:1
  • 8Dizendorf EV, Baumert BG, von Schulthess GK, et al, Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy[J]. J Nucl Med, 2003, 44(1):24-29. 被引量:1
  • 9Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study[J]. IntJ Radiat Oncol Biol Phys, 2003, 57(3):853-863. 被引量:1
  • 10Munley Mr, Marks LB, Scarfone C, et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects [J]. Lung Cancer,1999, 23(2):105-114. 被引量:1

共引文献44

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部